Loading…

Influence of Anti-TNF and Disease Modifying Antirheumatic Drugs Therapy on Pulmonary Forced Vital Capacity Associated to Ankylosing Spondylitis: A 2-Year Follow-Up Observational Study

Objective. To evaluate the effect of anti-TNF agents plus synthetic disease modifying antirheumatic drugs (DMARDs) versus DMARDs alone for ankylosing spondylitis (AS) with reduced pulmonary function vital capacity (FVC%). Methods. In an observational study, we included AS who had FVC%

Saved in:
Bibliographic Details
Published in:Journal of immunology research 2015-01, Vol.2015 (2015), p.1-8
Main Authors: Gonzalez-Lopez, Laura, Salazar-Paramo, Mario, Gamez-Nava, Jorge Ivan, Nava, Arnulfo, Davalos-Rodriguez, Ingrid Patricia, Rocha-Muñoz, Alberto Daniel, Brambila-Tapia, Aniel Jessica Leticia, Zavala-Cerna, María Guadalupe, Vasquez-Jimenez, Jose Clemente, De la Cerda-Trujillo, Liliana Faviola, Vázquez-Del Mercado, Mónica, Rodriguez-Jimenez, Norma Alejandra, Díaz-Rizo, Valeria, Díaz-González, Viviana, Cardona-Muñoz, Ernesto German
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective. To evaluate the effect of anti-TNF agents plus synthetic disease modifying antirheumatic drugs (DMARDs) versus DMARDs alone for ankylosing spondylitis (AS) with reduced pulmonary function vital capacity (FVC%). Methods. In an observational study, we included AS who had FVC%
ISSN:2314-8861
2314-7156
DOI:10.1155/2015/980147